TGFB1 and glioblastoma: It has been reported that HOXA13 may promote GBM progression through activation of Wnt/beta-catenin and TGF-β signaling pathway, whereas downregulation of HOXA13 may suppress GBM cell invasion and decrease tumor growth [22].